Pierre Sesques

18PUBLICATIONS

84CO-AUTHORS

Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Haematological tumoursApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Bacteriology

Get your video featured.

Publish with JoVE

Get your video featured.

Publish with JoVE

Publications (18)

Sort by Publication Date:

|May 12, 2026

Prognostic value of combined baseline FDG PET/CT radiomic parameters in primary mediastinal B-cell lymphoma.

|May 08, 2026

Outcomes and salvage strategies for large B-cell lymphoma progressing after second-line CAR T-cell therapy: A DESCAR-T study from the LYSA group.

|Apr 14, 2026

Interim assessment by circulating tumor DNA in primary mediastinal large B-cell lymphoma: a multicenter LYSA study.

Vincent Camus, Daphné Krzisch, Alessio Bruscaggin

|Feb 26, 2026

Patient-derived lymphoma spheroids reveal predictive markers of glofitamab resistance in relapsed/refractory B-NHL.

Paul Marcoux, Fabien Gava, Marie Tosolini

|Nov 03, 2025

Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials.

Valentin Letailleur, Isabelle Chaillol, Fanny Cherblanc

|Jul 12, 2025

Impact of Body Composition on Treatment Toxicity and Outcomes in Patients With Primary Mediastinal Large B-Cell Lymphoma.

Juliette Penichoux, Pierre Decazes, Cédric Rossi

Pageof 3

Frequent Collaborators

Vincent Camus

Eric Durot

Cédric Rossi

Marie Donzel

Sylvain Carras

Lucie Oberic

David Tonnelet

Pierre Decazes

Emmanuel Bachy

Franck Morschhauser

Frequent Collaborators

Vincent Camus

Eric Durot

Cédric Rossi

Marie Donzel